Vivoryon Therapeutics N.V./€VVY
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Vivoryon Therapeutics N.V.
Vivoryon Therapeutics N.V. is a biopharmaceutical company specializing in the development of small molecule-based medicines targeting post-translational modifications implicated in various diseases. () Its lead candidate, varoglutamstat, is an orally administered inhibitor of glutaminyl cyclases (QPCT and QPCTL), enzymes involved in pyroglutamate formation, with potential applications in inflammatory and fibrotic disorders. () Founded in 1997 as Probiodrug AG, the company rebranded to Vivoryon Therapeutics in 2019 to reflect its focus on therapeutic solutions for severe diseases. () Headquartered in Halle (Saale), Germany, Vivoryon has a strategic emphasis on leveraging its expertise in post-translational modifications to develop treatments for conditions with high unmet medical needs.
Ticker
€VVY
Sector
Primary listing
AEX
Industry
Biotechnology
Headquarters
Employees
14
ISIN
NL00150002Q7
Website
VVY Metrics
BasicAdvanced
€38M
-
-€0.79
1.96
-
Price and volume
Market cap
€38M
Beta
1.96
52-week high
€3.00
52-week low
€1.39
Average daily volume
72K
Financial strength
Current ratio
7.196
Quick ratio
6.932
Long term debt to equity
0.533
Total debt to equity
1.294
Interest coverage (TTM)
-243.77%
Profitability
EBITDA (TTM)
-20.817
Management effectiveness
Return on assets (TTM)
-62.22%
Return on equity (TTM)
-120.41%
Valuation
Price to book
4.76
Price to tangible book (TTM)
5.35
Price to free cash flow (TTM)
-1.971
Free cash flow yield (TTM)
-50.73%
Free cash flow per share (TTM)
-73.65%
Growth
Earnings per share change (TTM)
-29.64%
3-year earnings per share growth (CAGR)
7.64%
10-year earnings per share growth (CAGR)
-10.34%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Vivoryon Therapeutics N.V. stock?
Vivoryon Therapeutics N.V. (VVY) has a market cap of €38M as of July 02, 2025.
What is the P/E ratio for Vivoryon Therapeutics N.V. stock?
The price to earnings (P/E) ratio for Vivoryon Therapeutics N.V. (VVY) stock is 0 as of July 02, 2025.
Does Vivoryon Therapeutics N.V. stock pay dividends?
No, Vivoryon Therapeutics N.V. (VVY) stock does not pay dividends to its shareholders as of July 02, 2025.
When is the next Vivoryon Therapeutics N.V. dividend payment date?
Vivoryon Therapeutics N.V. (VVY) stock does not pay dividends to its shareholders.
What is the beta indicator for Vivoryon Therapeutics N.V.?
Vivoryon Therapeutics N.V. (VVY) has a beta rating of 1.96. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.